Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2026-02-07 @ 11:16 PM
Study NCT ID:
NCT00160693
Status:
COMPLETED
Last Update Posted:
2018-08-01
First Post:
2005-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis
Sponsor:
UCB Pharma
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |